Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02525692
Title Oral ONC201 in Recurrent GBM, H3 K27M Glioma, and Midline Glioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Oncoceutics, Inc.
Indications

glioblastoma

high grade glioma

Therapies

ONC201

Age Groups: child | adult | senior
Covered Countries USA

Additional content available in CKB BOOST